add share buttons

IMBAJP

Medtech Market Trends Backed by Life Science Intelligence Data

Gallery - Life Science Intelligence

The medical technology sector is experiencing a period of rapid change driven by innovation, rising levels of funding, and shifting healthcare requirements worldwide. Using data from Life Science Intelligence, companies and their investors will be able to see more clearly which trends are shaping the medtech industry’s growth over the next few years. The data presented at both the LSI Conference and the LSI Emerging Medtech Summit support this continued evolution, pointing to where companies have the best chances of success.

Examples of Major Medtech Trends, Based on Life Science Intelligence Data

Through the research conducted by Life Science Intelligence, we can identify five of the most significant trends occurring in today’s global medtech environment:

1) Integration of AI and machine learning into diagnostics, imaging, and monitoring;

2) Increasing patient demand for minimally invasive methods of treatment, especially in cardiology, orthopedics, and oncology;

3) Rise of remote patient monitoring (RPM) and connected devices;

4) Growing interest from investors in data analytics and digital therapeutics;

5) Accelerated interest in robotics and automation as tools to create greater efficiency in surgical and clinical care.

These five trends illustrate that hospitals, patients, and investors each have distinct priorities and needs. The future success of medtech companies will rely on their ability to meet these changing priorities.

Insights at the LSI Conference

There has been a very strong increase in funding activity for digital, AI and wearable technologies.

  • There is a high demand for new solutions that will enhance the operational efficiencies of hospitals.
  • There is a growing interest and enthusiasm for the next generation of technology solutions related to treating cardiovascular and neuro diseases.
  • There is also an increasing interest that the global market is scalable and the solutions will be ready for reimbursement.
  • This alignment gives increased reliability to the data-driven insights provided by LSI.

Validation of Deep-Dive at the LSI Emerging MedTech Summit

The LSI Emerging MedTech Summit also validated the above by:

  • Real world presentations from innovative companies in rapidly growing markets.
  • Investor insights regarding the technologies that will succeed from 2025-2027.
  • Market forecasts based on data indicating significant growth within the areas of neurostimulation, remote monitoring, and robotics.
  • Using this insight, companies will create and refine strategies with greater confidence.

With a strong foundation of Life Science Intelligence market research revealing an influential trend in medtech, coupled with expert insights from the LSI conference and the LSI Emerging MedTech Summit, MedTech companies have the clarity needed to successfully innovate, expand, and compete in an ever-changing, highly competitive global landscape.

IMBAJP